Company: ARMP
Filing Date: 2025-09-11
Form Type: 8-K
Source: 0001104659-25-089150
Chunk: 0

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-09-11
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01      Regulation FD Disclosure.  

The Company posted a corporate presentation dated September 10, 2025
(the “ H. C. Wainwright Presentation”), which is furnished as Exhibit 99.1 hereto, to its website at https://investor. armatapharma. com/image/Armata_+2025_HCW_Conference_+Sept_10_2025. pdf.
The H. C. Wainwright Presentation was delivered by Dr. Deborah Birx, M. D., the Company’s Chief Executive Officer, at the H. C. Wainwright
27th Annual Global Investment Conference held on September 10, 2025.

The information contained in the H. C. Wainwright Presentation is summary
information that is intended to be considered in the context of the Company’s Securities and Exchange Commission (“ SEC”)
filings and other public announcements that the Company may make, by press release or otherwise, from time to time. The Company undertakes
no duty or obligation to publicly update or revise the information contained in this report, except as may be required by the federal
securities laws, although it may do so from time to time as its management believes is warranted. Any such updating may be made through
the filing of other reports or documents with the SEC, through press releases or through other public disclosure. In addition, the Company
disclaims any inferences regarding the materiality of such information that may arise as a result of it furnishing such information under
Item 7.01 of this Current Report on Form 8-K.

The information in this Item 7.01 and the attached Exhibit 99.1 is
being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as
amended, or otherwise subject to the liabilities of that Section. The information in this Item 7.01 and the attached Exhibit 99.1 shall
not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.